Диссертация (1144259), страница 23

Просмтор этого файла доступен только зарегистрированным пользователям. Но у нас супер быстрая регистрация: достаточно только электронной почты!

Текст из файла (страница 23)

-- T. 100, № 8. -- C. 2033-42.[32] Ellisdon A. M., Thomas B., Bottomley S. P. The two-stage pathway of ataxin-3fibrillogenesis involves a polyglutamine-independent step // J Biol Chem. -- 2006. -Jun 23. -- T. 281, № 25. -- C. 16888-96.[33] Scarff C. A., Almeida B., Fraga J., Macedo-Ribeiro S., Radford S. E., Ashcroft A.E.

Examination of Ataxin-3 (atx-3) Aggregation by Structural Mass SpectrometryTechniques: A Rationale for Expedited Aggregation upon Polyglutamine (polyQ)Expansion // Mol Cell Proteomics. -- 2015. -- May. -- T. 14, № 5. -- C. 1241-53.[34] Monsellier E., Redeker V., Ruiz-Arlandis G., Bousset L., Melki R. Molecularinteraction between the chaperone Hsc70 and the N-terminal flank of huntingtin exon 1modulates aggregation // J Biol Chem. -- 2015. -- Jan 30. -- T. 290, № 5. -- C. 2560-76.[35] de Chiara C., Menon R. P., Dal Piaz F., Calder L., Pastore A. Polyglutamine is notall: the functional role of the AXH domain in the ataxin-1 protein // J Mol Biol.

-- 2005.-- Dec 9. -- T. 354, № 4. -- C. 883-93.[36] de Chiara C., Rees M., Menon R. P., Pauwels K., Lawrence C., Konarev P. V.,Svergun D. I., Martin S. R., Chen Y. W., Pastore A. Self-assembly and conformationalheterogeneity of the AXH domain of ataxin-1: an unusual example of a chameleon fold// Biophys J. -- 2013.

-- Mar 19. -- T. 104, № 6. -- C. 1304-13.[37] Asencio-Hernandez J., Ruhlmann C., McEwen A., Eberling P., Nomine Y.,Ceraline J., Starck J. P., Delsuc M. A. Reversible amyloid fiber formation in the Nterminus of androgen receptor // Chembiochem. -- 2014. -- Nov 3. -- T. 15, № 16. -- C.2370-3.[38] Oppong E., Stier G., Gaal M., Seeger R., Stoeck M., Delsuc M.

A., Cato A. C. B.,Kieffer B. An Amyloidogenic Sequence at the N-Terminus of the Androgen ReceptorImpacts Polyglutamine Aggregation // Biomolecules. -- 2017. -- Jun 19. -- T. 7, № 2.[39] Berke S. J., Schmied F. A., Brunt E. R., Ellerby L. M., Paulson H.

L. Caspasemediated proteolysis of the polyglutamine disease protein ataxin-3 // J Neurochem. -2004. -- May. -- T. 89, № 4. -- C. 908-18.[40] Bushart D. D., Shakkottai V. G. Ion channel dysfunction in cerebellar ataxia //Neurosci Lett. -- 2018. -- Feb 5.- 129 -[41] Chen X., Tang T. S., Tu H., Nelson O., Pook M., Hammer R., Nukina N.,Bezprozvanny I.

Deranged calcium signaling and neurodegeneration in spinocerebellarataxia type 3 // J Neurosci. -- 2008. -- Nov 26. -- T. 28, № 48. -- C. 12713-24.[42] Chou A. H., Yeh T. H., Ouyang P., Chen Y. L., Chen S. Y., Wang H. L.Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenicmice by inducing transcriptional dysregulation // Neurobiol Dis.

-- 2008. -- Jul. -- T. 31,№ 1. -- C. 89-101.[43] Matsumoto M., Yada M., Hatakeyama S., Ishimoto H., Tanimura T., Tsuji S.,Kakizuka A., Kitagawa M., Nakayama K. I. Molecular clearance of ataxin-3 isregulated by a mammalian E4 // EMBO J. -- 2004. -- Feb 11. -- T. 23, № 3.

-- C. 65969.[44] Evert B. O., Araujo J., Vieira-Saecker A. M., de Vos R. A., Harendza S.,Klockgether T., Wullner U. Ataxin-3 represses transcription via chromatin binding,interaction with histone deacetylase 3, and histone deacetylation // J Neurosci. -- 2006. - Nov 1. -- T. 26, № 44. -- C. 11474-86.[45] Bugg C. W., Isas J. M., Fischer T., Patterson P. H., Langen R. Structural featuresand domain organization of huntingtin fibrils // J Biol Chem.

-- 2012. -- Sep 14. -- T.287, № 38. -- C. 31739-46.[46] Fodale V., Kegulian N. C., Verani M., Cariulo C., Azzollini L., Petricca L., DaldinM., Boggio R., Padova A., Kuhn R., Pacifici R., Macdonald D., Schoenfeld R. C., ParkH., Isas J. M., Langen R., Weiss A., Caricasole A. Polyglutamine- and temperaturedependent conformational rigidity in mutant huntingtin revealed by immunoassays andcircular dichroism spectroscopy // PLoS One. -- 2014. -- T.

9, № 12. -- C. e112262.[47] Michalek M., Salnikov E. S., Bechinger B. Structure and topology of the huntingtin1-17 membrane anchor by a combined solution and solid-state NMR approach //Biophys J. -- 2013. -- Aug 6. -- T. 105, № 3. -- C. 699-710.[48] Michalek M., Salnikov E. S., Werten S., Bechinger B.

Membrane interactions ofthe amphipathic amino terminus of huntingtin // Biochemistry. -- 2013. -- Feb 5. -- T.52, № 5. -- C. 847-58.[49] Dlugosz M., Trylska J. Secondary structures of native and pathogenic huntingtinN-terminal fragments // J Phys Chem B. -- 2011. -- Oct 13. -- T. 115, № 40. -- C.11597-608.[50] Zhou Z. L., Zhao J.

H., Liu H. L., Wu J. W., Liu K. T., Chuang C. K., Tsai W. B.,Ho Y. The possible structural models for polyglutamine aggregation: a moleculardynamics simulations study // J Biomol Struct Dyn. -- 2011. -- Apr. -- T. 28, № 5. -- C.743-58.[51] Ogawa H., Nakano M., Watanabe H., Starikov E. B., Rothstein S. M., Tanaka S.Molecular dynamics simulation study on the structural stabilities of polyglutaminepeptides // Comput Biol Chem. -- 2008. -- Apr. -- T. 32, № 2. -- C. 102-10.[52] Gomez-Sicilia A., Sikora M., Cieplak M., Carrion-Vazquez M. An Exploration ofthe Universe of Polyglutamine Structures // PLoS Comput Biol. -- 2015. -- Oct.

-- T. 11,№ 10. -- C. e1004541.[53] Li P., Huey-Tubman K. E., Gao T., Li X., West A. P., Jr., Bennett M. J., BjorkmanP. J. The structure of a polyQ-anti-polyQ complex reveals binding according to a linearlattice model // Nat Struct Mol Biol.

-- 2007. -- May. -- T. 14, № 5. -- C. 381-7.- 130 -[54] Kim M. Beta conformation of polyglutamine track revealed by a crystal structureof Huntingtin N-terminal region with insertion of three histidine residues // Prion. -2013. -- May-Jun. -- T. 7, № 3. -- C. 221-8.[55] Kim M. W., Chelliah Y., Kim S. W., Otwinowski Z., Bezprozvanny I. Secondarystructure of Huntingtin amino-terminal region // Structure. -- 2009.

-- Sep 09. -- T. 17,№ 9. -- C. 1205-12.[56] Berman H. M., Westbrook J., Feng Z., Gilliland G., Bhat T. N., Weissig H.,Shindyalov I. N., Bourne P. E. The Protein Data Bank // Nucleic Acids Res. -- 2000. -Jan 1. -- T. 28, № 1. -- C. 235-42.[57] Shi Y. A glimpse of structural biology through X-ray crystallography // Cell. -2014. -- Nov 20. -- T. 159, № 5. -- C. 995-1014.[58] MacDonald M. E., Ambrose C. M., Duyao M. P., Myers R.

H., Lin C., Srinidhi L.,Barnes G., Taylor S. A., James M., Groot N., MacFarlane H., Jenkins B., Anderson M.A., Wexler N. S., Gusella J. F., Bates G. P., Baxendale S., Hummerich H., Kirby S.,North M., Youngman S., Mott R., Zehetner G., Sedlacek Z., Poustka A., Frischauf A.M., Lehrach H., Buckler A. J., Church D., Doucette-Stamm L., O'Donovan M.

C., RibaRamirez L., Shah M., Stanton V. P., Strobel S. A., Draths K. M., Wales J. L., Dervan P.,Housman D. E., Altherr M., Shiang R., Thompson L., Fielder T., Wasmuth J. J., TagleD., Valdes J., Elmer L., Allard M., Castilla L., Swaroop M., Blanchard K., Collins F. S.,Snell R., Holloway T., Gillespie K., Datson N., Shaw D., Harper P.

S. A novel genecontaining a trinucleotide repeat that is expanded and unstable on Huntington's diseasechromosomes // Cell -- T. 72, № 6. -- C. 971-983.[59] Harper P. S. The epidemiology of Huntington's disease // Hum Genet. -- 1992. -Jun. -- T. 89, № 4. -- C. 365-76.[60] Vonsattel J. P., Myers R. H., Stevens T.

J., Ferrante R. J., Bird E. D., Richardson E.P., Jr. Neuropathological classification of Huntington's disease // J Neuropathol ExpNeurol. -- 1985. -- Nov. -- T. 44, № 6. -- C. 559-77.[61] Myers R. H., Sax D. S., Schoenfeld M., Bird E. D., Wolf P.

A., Vonsattel J. P.,White R. F., Martin J. B. Late onset of Huntington's disease // J Neurol NeurosurgPsychiatry. -- 1985. -- Jun. -- T. 48, № 6. -- C. 530-4.[62] Andrew S. E., Goldberg Y. P., Kremer B., Telenius H., Theilmann J., Adam S.,Starr E., Squitieri F., Lin B., Kalchman M. A., et al. The relationship betweentrinucleotide (CAG) repeat length and clinical features of Huntington's disease // NatGenet. -- 1993. -- Aug.

-- T. 4, № 4. -- C. 398-403.[63] Shirasaki D. I., Greiner E. R., Al-Ramahi I., Gray M., Boontheung P., GeschwindD. H., Botas J., Coppola G., Horvath S., Loo J. A., Yang X. W. Network organizationof the huntingtin proteomic interactome in mammalian brain // Neuron. -- 2012. -- Jul12. -- T. 75, № 1. -- C. 41-57.[64] DiFiglia M., Sapp E., Chase K., Schwarz C., Meloni A., Young C., Martin E.,Vonsattel J. P., Carraway R., Reeves S. A., et al. Huntingtin is a cytoplasmic proteinassociated with vesicles in human and rat brain neurons // Neuron. -- 1995. -- May.

-- T.14, № 5. -- C. 1075-81.[65] De Rooij K. E., Dorsman J. C., Smoor M. A., Den Dunnen J. T., Van Ommen G. J.Subcellular localization of the Huntington's disease gene product in cell lines by- 131 -immunofluorescence and biochemical subcellular fractionation // Hum Mol Genet. -1996. -- Aug. -- T. 5, № 8. -- C. 1093-9.[66] Atwal R. S., Xia J., Pinchev D., Taylor J., Epand R. M., Truant R. Huntingtin has amembrane association signal that can modulate huntingtin aggregation, nuclear entryand toxicity // Hum Mol Genet. -- 2007. -- Nov 1. -- T. 16, № 21. -- C.

2600-15.[67] Rockabrand E., Slepko N., Pantalone A., Nukala V. N., Kazantsev A., Marsh J. L.,Sullivan P. G., Steffan J. S., Sensi S. L., Thompson L. M. The first 17 amino acids ofHuntingtin modulate its sub-cellular localization, aggregation and effects on calciumhomeostasis // Hum Mol Genet.

Характеристики

Список файлов диссертации